Camlin Fine

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE052I01032
  • NSEID: CAMLINFINE
  • BSEID: 532834
INR
126.00
1.65 (1.33%)
BSENSE

Aug 11

BSE+NSE Vol: 5.67 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 256060,
    "name": "Camlin Fine",
    "stock_name": "Camlin Fine",
    "full_name": "Camlin Fine Sciences Ltd",
    "name_url": "stocks-analysis/camlin-fine",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "126.00",
    "chg": 1.65,
    "chgp": "1.33%",
    "dir": 1,
    "prev_price": "124.35",
    "mcapval": "2,433.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532834,
    "symbol": "CAMLINFINE",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "India SENSEX",
    "isin": "INE052I01032",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "5.67 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/camlin-fine-256060-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Camlin Fine Sciences reports consolidated net profit of Rs 88.20 crore in the March 2026 quarter",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-27 10:27:29",
        "description": "Camlin Fine Sciences reports consolidated net profit of Rs 88.20 crore in the March 2026 quarter  Business Standard..."
      },
      {
        "title": "Board of Camlin Fine Sciences approves change in CFO",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-26 19:16:02",
        "description": "Board of Camlin Fine Sciences approves change in CFO  Business Standard..."
      }
    ],
    "total": 2,
    "sid": "256060",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/camlin-fine-sciences-256060"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "04-Aug-2026",
      "details": "Schedule of Investor Meet - Q1FY27 Earnings Call",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of The Un-Audited Standalone And Consolidate Financial Results Of The Company For The Quarter Ended June 30 2026.",
      "datetime": "04-Aug-2026",
      "details": "Camlin Fine Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the Un-audited Standalone and Consolidate Financial Results of the Company for the quarter ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
      "datetime": "28-Jul-2026",
      "details": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 28 2026 for Ashish Subhash Dandekar",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(11 Aug 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Camlin Fine Sciences Ltd has declared <strong>45%</strong> dividend, ex-date: 28 Jul 16",
          "dt": "2016-07-28",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Camlin Fine Sciences Ltd has announced <strong>1:2</strong> stock split, ex-date: 04 Sep 14",
          "dt": "2014-09-04",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Camlin Fine Sciences Ltd has announced <strong>5:41</strong> rights issue, ex-date: 08 Jan 25",
          "dt": "2025-01-08",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

04-Aug-2026 | Source : BSE

Schedule of Investor Meet - Q1FY27 Earnings Call

Board Meeting Intimation for Consideration And Approval Of The Un-Audited Standalone And Consolidate Financial Results Of The Company For The Quarter Ended June 30 2026.

04-Aug-2026 | Source : BSE

Camlin Fine Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the Un-audited Standalone and Consolidate Financial Results of the Company for the quarter ended June 30 2026.

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

28-Jul-2026 | Source : BSE

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 28 2026 for Ashish Subhash Dandekar

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

(11 Aug 2026)

stock-summary
DIVIDEND

Camlin Fine Sciences Ltd has declared 45% dividend, ex-date: 28 Jul 16

stock-summary
SPLITS

Camlin Fine Sciences Ltd has announced 1:2 stock split, ex-date: 04 Sep 14

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Camlin Fine Sciences Ltd has announced 5:41 rights issue, ex-date: 08 Jan 25